Global Remicade Biosimilar Market Research Report 2017

December 2017 | 107 pages | ID: GFCD96EA2B1EN
QYResearch

Abstracts

In this report, the global Remicade Biosimilar market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Remicade Biosimilar in these regions, from 2012 to 2022 (forecast), covering

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Global Remicade Biosimilar market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

• Teva Pharmaceutical Industries
• Synthon Pharmaceuticals
• LG Life Sciences
• Novartis (Sandoz)
• Celltrion
• Biocon
• Hospira
• Merck Serono (Merck Group)
• Biogen idec Inc.
• Genentech (Roche Group)

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• 100mg/10ml
• 500mg/50ml

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

• Blood Disorders
• Oncology Diseases

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Remicade Biosimilar Market Research Report 2017

1 REMICADE BIOSIMILAR MARKET OVERVIEW

1.1 Product Overview and Scope of Remicade Biosimilar
1.2 Remicade Biosimilar Segment by Type (Product Category)
  1.2.1 Global Remicade Biosimilar Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
  1.2.2 Global Remicade Biosimilar Production Market Share by Type (Product Category) in 2016
  1.2.3 100mg/10ml
  1.2.4 500mg/50ml
1.3 Global Remicade Biosimilar Segment by Application
  1.3.1 Remicade Biosimilar Consumption (Sales) Comparison by Application (2012-2022)
  1.3.2 Blood Disorders
  1.3.3 Oncology Diseases
1.4 Global Remicade Biosimilar Market by Region (2012-2022)
  1.4.1 Global Remicade Biosimilar Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
  1.4.2 North America Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 China Status and Prospect (2012-2022)
  1.4.5 Japan Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Status and Prospect (2012-2022)
  1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Remicade Biosimilar (2012-2022)
  1.5.1 Global Remicade Biosimilar Revenue Status and Outlook (2012-2022)
  1.5.2 Global Remicade Biosimilar Capacity, Production Status and Outlook (2012-2022)

2 GLOBAL REMICADE BIOSIMILAR MARKET COMPETITION BY MANUFACTURERS

2.1 Global Remicade Biosimilar Capacity, Production and Share by Manufacturers (2012-2017)
  2.1.1 Global Remicade Biosimilar Capacity and Share by Manufacturers (2012-2017)
  2.1.2 Global Remicade Biosimilar Production and Share by Manufacturers (2012-2017)
2.2 Global Remicade Biosimilar Revenue and Share by Manufacturers (2012-2017)
2.3 Global Remicade Biosimilar Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Remicade Biosimilar Manufacturing Base Distribution, Sales Area and Product Type
2.5 Remicade Biosimilar Market Competitive Situation and Trends
  2.5.1 Remicade Biosimilar Market Concentration Rate
  2.5.2 Remicade Biosimilar Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL REMICADE BIOSIMILAR CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global Remicade Biosimilar Capacity and Market Share by Region (2012-2017)
3.2 Global Remicade Biosimilar Production and Market Share by Region (2012-2017)
3.3 Global Remicade Biosimilar Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Remicade Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Remicade Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Remicade Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Remicade Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Remicade Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Remicade Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Remicade Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL REMICADE BIOSIMILAR SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2012-2017)

4.1 Global Remicade Biosimilar Consumption by Region (2012-2017)
4.2 North America Remicade Biosimilar Production, Consumption, Export, Import (2012-2017)
4.3 Europe Remicade Biosimilar Production, Consumption, Export, Import (2012-2017)
4.4 China Remicade Biosimilar Production, Consumption, Export, Import (2012-2017)
4.5 Japan Remicade Biosimilar Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Remicade Biosimilar Production, Consumption, Export, Import (2012-2017)
4.7 India Remicade Biosimilar Production, Consumption, Export, Import (2012-2017)

5 GLOBAL REMICADE BIOSIMILAR PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Remicade Biosimilar Production and Market Share by Type (2012-2017)
5.2 Global Remicade Biosimilar Revenue and Market Share by Type (2012-2017)
5.3 Global Remicade Biosimilar Price by Type (2012-2017)
5.4 Global Remicade Biosimilar Production Growth by Type (2012-2017)

6 GLOBAL REMICADE BIOSIMILAR MARKET ANALYSIS BY APPLICATION

6.1 Global Remicade Biosimilar Consumption and Market Share by Application (2012-2017)
6.2 Global Remicade Biosimilar Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL REMICADE BIOSIMILAR MANUFACTURERS PROFILES/ANALYSIS

7.1 Teva Pharmaceutical Industries
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Remicade Biosimilar Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Teva Pharmaceutical Industries Remicade Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Main Business/Business Overview
7.2 Synthon Pharmaceuticals
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Remicade Biosimilar Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Synthon Pharmaceuticals Remicade Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Main Business/Business Overview
7.3 LG Life Sciences
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Remicade Biosimilar Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 LG Life Sciences Remicade Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Main Business/Business Overview
7.4 Novartis (Sandoz)
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Remicade Biosimilar Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Novartis (Sandoz) Remicade Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Main Business/Business Overview
7.5 Celltrion
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Remicade Biosimilar Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Celltrion Remicade Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Main Business/Business Overview
7.6 Biocon
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Remicade Biosimilar Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Biocon Remicade Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Main Business/Business Overview
7.7 Hospira
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Remicade Biosimilar Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Hospira Remicade Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Main Business/Business Overview
7.8 Merck Serono (Merck Group)
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 Remicade Biosimilar Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Merck Serono (Merck Group) Remicade Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Main Business/Business Overview
7.9 Biogen idec Inc.
  7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.9.2 Remicade Biosimilar Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Biogen idec Inc. Remicade Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Main Business/Business Overview
7.10 Genentech (Roche Group)
  7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.10.2 Remicade Biosimilar Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Genentech (Roche Group) Remicade Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.10.4 Main Business/Business Overview

8 REMICADE BIOSIMILAR MANUFACTURING COST ANALYSIS

8.1 Remicade Biosimilar Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Remicade Biosimilar

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Remicade Biosimilar Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Remicade Biosimilar Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL REMICADE BIOSIMILAR MARKET FORECAST (2017-2022)

12.1 Global Remicade Biosimilar Capacity, Production, Revenue Forecast (2017-2022)
  12.1.1 Global Remicade Biosimilar Capacity, Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global Remicade Biosimilar Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global Remicade Biosimilar Price and Trend Forecast (2017-2022)
12.2 Global Remicade Biosimilar Production, Consumption, Import and Export Forecast by Region (2017-2022)
  12.2.1 North America Remicade Biosimilar Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe Remicade Biosimilar Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China Remicade Biosimilar Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan Remicade Biosimilar Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia Remicade Biosimilar Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India Remicade Biosimilar Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Remicade Biosimilar Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Remicade Biosimilar Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Remicade Biosimilar
Figure Global Remicade Biosimilar Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Remicade Biosimilar Production Market Share by Types (Product Category) in 2016
Figure Product Picture of 100mg/10ml
Table Major Manufacturers of 100mg/10ml
Figure Product Picture of 500mg/50ml
Table Major Manufacturers of 500mg/50ml
Figure Global Remicade Biosimilar Consumption (K Units) by Applications (2012-2022)
Figure Global Remicade Biosimilar Consumption Market Share by Applications in 2016
Figure Blood Disorders Examples
Table Key Downstream Customer in Blood Disorders
Figure Oncology Diseases Examples
Table Key Downstream Customer in Oncology Diseases
Figure Global Remicade Biosimilar Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2012-2022)
Figure North America Remicade Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Remicade Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Remicade Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Remicade Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Remicade Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Remicade Biosimilar Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Remicade Biosimilar Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Remicade Biosimilar Capacity, Production (K Units) Status and Outlook (2012-2022)
Figure Global Remicade Biosimilar Major Players Product Capacity (K Units) (2012-2017)
Table Global Remicade Biosimilar Capacity (K Units) of Key Manufacturers (2012-2017)
Table Global Remicade Biosimilar Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Remicade Biosimilar Capacity (K Units) of Key Manufacturers in 2016
Figure Global Remicade Biosimilar Capacity (K Units) of Key Manufacturers in 2017
Figure Global Remicade Biosimilar Major Players Product Production (K Units) (2012-2017)
Table Global Remicade Biosimilar Production (K Units) of Key Manufacturers (2012-2017)
Table Global Remicade Biosimilar Production Share by Manufacturers (2012-2017)
Figure 2016 Remicade Biosimilar Production Share by Manufacturers
Figure 2017 Remicade Biosimilar Production Share by Manufacturers
Figure Global Remicade Biosimilar Major Players Product Revenue (Million USD) (2012-2017)
Table Global Remicade Biosimilar Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Remicade Biosimilar Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Remicade Biosimilar Revenue Share by Manufacturers
Table 2017 Global Remicade Biosimilar Revenue Share by Manufacturers
Table Global Market Remicade Biosimilar Average Price (USD/Unit) of Key Manufacturers (2012-2017)
Figure Global Market Remicade Biosimilar Average Price (USD/Unit) of Key Manufacturers in 2016
Table Manufacturers Remicade Biosimilar Manufacturing Base Distribution and Sales Area
Table Manufacturers Remicade Biosimilar Product Category
Figure Remicade Biosimilar Market Share of Top 3 Manufacturers
Figure Remicade Biosimilar Market Share of Top 5 Manufacturers
Table Global Remicade Biosimilar Capacity (K Units) by Region (2012-2017)
Figure Global Remicade Biosimilar Capacity Market Share by Region (2012-2017)
Figure Global Remicade Biosimilar Capacity Market Share by Region (2012-2017)
Figure 2016 Global Remicade Biosimilar Capacity Market Share by Region
Table Global Remicade Biosimilar Production by Region (2012-2017)
Figure Global Remicade Biosimilar Production (K Units) by Region (2012-2017)
Figure Global Remicade Biosimilar Production Market Share by Region (2012-2017)
Figure 2016 Global Remicade Biosimilar Production Market Share by Region
Table Global Remicade Biosimilar Revenue (Million USD) by Region (2012-2017)
Table Global Remicade Biosimilar Revenue Market Share by Region (2012-2017)
Figure Global Remicade Biosimilar Revenue Market Share by Region (2012-2017)
Table 2016 Global Remicade Biosimilar Revenue Market Share by Region
Figure Global Remicade Biosimilar Capacity, Production (K Units) and Growth Rate (2012-2017)
Table Global Remicade Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table North America Remicade Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Europe Remicade Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table China Remicade Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Japan Remicade Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Southeast Asia Remicade Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table India Remicade Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Global Remicade Biosimilar Consumption (K Units) Market by Region (2012-2017)
Table Global Remicade Biosimilar Consumption Market Share by Region (2012-2017)
Figure Global Remicade Biosimilar Consumption Market Share by Region (2012-2017)
Figure 2016 Global Remicade Biosimilar Consumption (K Units) Market Share by Region
Table North America Remicade Biosimilar Production, Consumption, Import & Export (K Units) (2012-2017)
Table Europe Remicade Biosimilar Production, Consumption, Import & Export (K Units) (2012-2017)
Table China Remicade Biosimilar Production, Consumption, Import & Export (K Units) (2012-2017)
Table Japan Remicade Biosimilar Production, Consumption, Import & Export (K Units) (2012-2017)
Table Southeast Asia Remicade Biosimilar Production, Consumption, Import & Export (K Units) (2012-2017)
Table India Remicade Biosimilar Production, Consumption, Import & Export (K Units) (2012-2017)
Table Global Remicade Biosimilar Production (K Units) by Type (2012-2017)
Table Global Remicade Biosimilar Production Share by Type (2012-2017)
Figure Production Market Share of Remicade Biosimilar by Type (2012-2017)
Figure 2016 Production Market Share of Remicade Biosimilar by Type
Table Global Remicade Biosimilar Revenue (Million USD) by Type (2012-2017)
Table Global Remicade Biosimilar Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Remicade Biosimilar by Type (2012-2017)
Figure 2016 Revenue Market Share of Remicade Biosimilar by Type
Table Global Remicade Biosimilar Price (USD/Unit) by Type (2012-2017)
Figure Global Remicade Biosimilar Production Growth by Type (2012-2017)
Table Global Remicade Biosimilar Consumption (K Units) by Application (2012-2017)
Table Global Remicade Biosimilar Consumption Market Share by Application (2012-2017)
Figure Global Remicade Biosimilar Consumption Market Share by Applications (2012-2017)
Figure Global Remicade Biosimilar Consumption Market Share by Application in 2016
Table Global Remicade Biosimilar Consumption Growth Rate by Application (2012-2017)
Figure Global Remicade Biosimilar Consumption Growth Rate by Application (2012-2017)
Table Teva Pharmaceutical Industries Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Pharmaceutical Industries Remicade Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Industries Remicade Biosimilar Production Growth Rate (2012-2017)
Figure Teva Pharmaceutical Industries Remicade Biosimilar Production Market Share (2012-2017)
Figure Teva Pharmaceutical Industries Remicade Biosimilar Revenue Market Share (2012-2017)
Table Synthon Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Synthon Pharmaceuticals Remicade Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Synthon Pharmaceuticals Remicade Biosimilar Production Growth Rate (2012-2017)
Figure Synthon Pharmaceuticals Remicade Biosimilar Production Market Share (2012-2017)
Figure Synthon Pharmaceuticals Remicade Biosimilar Revenue Market Share (2012-2017)
Table LG Life Sciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table LG Life Sciences Remicade Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure LG Life Sciences Remicade Biosimilar Production Growth Rate (2012-2017)
Figure LG Life Sciences Remicade Biosimilar Production Market Share (2012-2017)
Figure LG Life Sciences Remicade Biosimilar Revenue Market Share (2012-2017)
Table Novartis (Sandoz) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis (Sandoz) Remicade Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis (Sandoz) Remicade Biosimilar Production Growth Rate (2012-2017)
Figure Novartis (Sandoz) Remicade Biosimilar Production Market Share (2012-2017)
Figure Novartis (Sandoz) Remicade Biosimilar Revenue Market Share (2012-2017)
Table Celltrion Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celltrion Remicade Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Celltrion Remicade Biosimilar Production Growth Rate (2012-2017)
Figure Celltrion Remicade Biosimilar Production Market Share (2012-2017)
Figure Celltrion Remicade Biosimilar Revenue Market Share (2012-2017)
Table Biocon Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biocon Remicade Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biocon Remicade Biosimilar Production Growth Rate (2012-2017)
Figure Biocon Remicade Biosimilar Production Market Share (2012-2017)
Figure Biocon Remicade Biosimilar Revenue Market Share (2012-2017)
Table Hospira Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hospira Remicade Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Hospira Remicade Biosimilar Production Growth Rate (2012-2017)
Figure Hospira Remicade Biosimilar Production Market Share (2012-2017)
Figure Hospira Remicade Biosimilar Revenue Market Share (2012-2017)
Table Merck Serono (Merck Group) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Serono (Merck Group) Remicade Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Serono (Merck Group) Remicade Biosimilar Production Growth Rate (2012-2017)
Figure Merck Serono (Merck Group) Remicade Biosimilar Production Market Share (2012-2017)
Figure Merck Serono (Merck Group) Remicade Biosimilar Revenue Market Share (2012-2017)
Table Biogen idec Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biogen idec Inc. Remicade Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biogen idec Inc. Remicade Biosimilar Production Growth Rate (2012-2017)
Figure Biogen idec Inc. Remicade Biosimilar Production Market Share (2012-2017)
Figure Biogen idec Inc. Remicade Biosimilar Revenue Market Share (2012-2017)
Table Genentech (Roche Group) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Genentech (Roche Group) Remicade Biosimilar Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Genentech (Roche Group) Remicade Biosimilar Production Growth Rate (2012-2017)
Figure Genentech (Roche Group) Remicade Biosimilar Production Market Share (2012-2017)
Figure Genentech (Roche Group) Remicade Biosimilar Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Remicade Biosimilar
Figure Manufacturing Process Analysis of Remicade Biosimilar
Figure Remicade Biosimilar Industrial Chain Analysis
Table Raw Materials Sources of Remicade Biosimilar Major Manufacturers in 2016
Table Major Buyers of Remicade Biosimilar
Table Distributors/Traders List
Figure Global Remicade Biosimilar Capacity, Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Remicade Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Remicade Biosimilar Price (Million USD) and Trend Forecast (2017-2022)
Table Global Remicade Biosimilar Production (K Units) Forecast by Region (2017-2022)
Figure Global Remicade Biosimilar Production Market Share Forecast by Region (2017-2022)
Table Global Remicade Biosimilar Consumption (K Units) Forecast by Region (2017-2022)
Figure Global Remicade Biosimilar Consumption Market Share Forecast by Region (2017-2022)
Figure North America Remicade Biosimilar Production (K Units) and Growth Rate Forecast (2017-2022)
Figure North America Remicade Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Remicade Biosimilar Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Europe Remicade Biosimilar Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Remicade Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Remicade Biosimilar Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure China Remicade Biosimilar Production (K Units) and Growth Rate Forecast (2017-2022)
Figure China Remicade Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Remicade Biosimilar Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Japan Remicade Biosimilar Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Remicade Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Remicade Biosimilar Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Southeast Asia Remicade Biosimilar Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Remicade Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Remicade Biosimilar Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure India Remicade Biosimilar Production (K Units) and Growth Rate Forecast (2017-2022)
Figure India Remicade Biosimilar Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Remicade Biosimilar Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Table Global Remicade Biosimilar Production (K Units) Forecast by Type (2017-2022)
Figure Global Remicade Biosimilar Production (K Units) Forecast by Type (2017-2022)
Table Global Remicade Biosimilar Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Remicade Biosimilar Revenue Market Share Forecast by Type (2017-2022)
Table Global Remicade Biosimilar Price Forecast by Type (2017-2022)
Table Global Remicade Biosimilar Consumption (K Units) Forecast by Application (2017-2022)
Figure Global Remicade Biosimilar Consumption (K Units) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source